DJIA 17,814.94 -2.96 -0.02%
NASDAQ 4,758.25 3.36 0.07%
S&P 500 2,067.03 -2.38 -0.12%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)



company name or ticker

Sector Update: Strong Advance for Health Care Sector; Sarepta Therapeutics Up After Positive Results

Sector Update: Strong Advance for Health Care Sector; Sarepta Therapeutics Up After Positive Results for Possible Ebola Treatment

Sector Update: Health Care

Ebola Stocks Move in Different Directions

Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

Benzinga's Top #PreMarket Gainers

Ebola Stocks on the Move

Ebola: Is The Cure Out There?

Prosensa Starts Rolling NDA Submission for Drisapersen - Analyst Blog

Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study

Is Sarepta Therapeutics Inc. Stock a Short Sell?

Clinical stage biopharma Sarepta Therapeutics has attracted a large and growing short interest. Is the stock now a good short sell?
See More Articles...